April 16, 2019 US shutdown dampens first-quarter flotations Biopharma IPOs dipped in the opening months of 2019, but numbers look fairly healthy despite January's US government closure.
July 09, 2018 The venture money keeps flowing for biopharma Private drug developers raised a record $8.5bn in the first half of 2018, amid a surge in mega rounds.
